"Vibe-chemist" uses ChatGPT to design and synthesize an experimental schizophrenia drug in his garage
Polymarket · x · 2026-09-09
According to a Polymarket alert, self-described "vibe-chemist" Douglas Yao used ChatGPT to help design and synthesize an experimental schizophrenia drug in his garage, claiming it showed antipsychotic effects in mice.
The case highlights how AI is lowering the barrier to drug design while raising safety and compliance questions about at-home synthesis.
Related event: Vibe Chemist Synthesizes Experimental Antipsychotic with ChatGPT in Garage(2 posts)→
More from AGI Musings
- If AI proved P=NP, it would imply insights humans lack, argues jessi_cata — jessi_cata · 2026-09-09
- Roko's Bet: If AI Solves P vs NP Soon, It'll Be P=NP Via an Ugly Algorithm — jessi_cata · 2026-09-09
- Roko bets AI cracks P vs NP soon — and the answer will likely be P=NP — RokoMijic · 2026-09-09
- "We're the First and Last Generation to Code for a Living" — tlakomy · 2026-09-09
- Plan alleged to lure academics with limited AI compute, then run their ideas in-house — ns123abc · 2026-09-09
- Brundage: my critique indicts the industry and policymakers, not just OpenAI — Miles_Brundage · 2026-09-09